Linda Buckingham, | |
1397 Weimer Rd, Diabetes Management Program, Taos, NM 87571-6253 | |
(575) 737-3285 | |
Not Available |
Full Name | Linda Buckingham |
---|---|
Gender | Female |
Speciality | Registered Nurse - Diabetes Educator |
Location | 1397 Weimer Rd, Taos, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073872057 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WD0400X | Registered Nurse - Diabetes Educator | R22682 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Linda Buckingham, 1397 Weimer Rd, Diabetes Management Program, Taos, NM 87571-6253 Ph: () - | Linda Buckingham, 1397 Weimer Rd, Diabetes Management Program, Taos, NM 87571-6253 Ph: (575) 737-3285 |
News Archive
When men outnumber women, females marry younger and the age gap between spouses grows, a University of Michigan study shows.
How quickly do we experience the benefits of exercise? A new University of Maryland study of healthy older adults shows that just one session of exercise increased activation in the brain circuits associated with memory - including the hippocampus - which shrinks with age and is the brain region attacked first in Alzheimer's disease.
Primary health care providers should incorporate human immunodeficiency virus (HIV) testing into routine patient care for all sexually active individuals, regardless of risk factors, say a group of physician/researchers at Emory University School of Medicine, Brown Medical School, and the Johns Hopkins School of Medicine.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.
› Verified 1 days ago
Susan M. Akins, C.N.M. Registered Nurse Medicare: Medicare Enrolled Practice Location: 1331 Maestas Rd, Taos, NM 87571 Phone: 575-758-5001 Fax: 575-737-5046 | |
Apryl Deherrera, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 310 Camino De La Placita, Taos, NM 87571 Phone: 575-770-8038 | |
Danette Quintan, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 320 Chamisa Rd, Taos, NM 87571 Phone: 575-770-6795 | |
Brock Reed, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1090 Goat Springs Road, Taos, NM 87571 Phone: 575-758-6966 Fax: 575-751-5214 | |
Jason A Ormsby, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 Paseo Del Canon E, Taos, NM 87571 Phone: 575-737-6016 | |
Josephine Binford, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1090 Goat Springs Road, Taos, NM 87571 Phone: 505-758-4224 Fax: 505-751-5211 |